Ensign Peak Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18M | Sell |
|
|||||
|
2025
Q1 | $16.7M | Sell |
|
|||||
|
2024
Q4 | $21.3M | Sell |
|
|||||
|
2024
Q3 | $18.7M | Sell |
|
|||||
|
2024
Q2 | $35.2M | Sell |
|
|||||
|
2024
Q1 | $46.9M | Sell |
|
|||||
|
2023
Q4 | $129M | Buy |
|
|||||
|
2023
Q3 | $63.3M | Buy |
|
|||||
|
2023
Q2 | $32.6M | Buy |
|
|||||
|
2023
Q1 | $21.8M | Buy |
|
|||||
|
2022
Q4 | $20.9M | Buy |
|
|||||
|
2022
Q3 | $8.09M | Sell |
|
|||||
|
2022
Q2 | $11.1M | Sell |
|
|||||
|
2022
Q1 | $19.8M | Sell |
|
|||||
|
2021
Q4 | $37.9M | Buy |
|
|||||
|
2021
Q3 | $37.6M | Buy |
|
|||||
|
2021
Q2 | $27.2M | Buy |
|
|||||
|
2021
Q1 | $22.6M | Buy |
|
|||||
|
2020
Q4 | $20.6M | Buy |
|
|||||
|
2020
Q3 | $8.05M | Buy |
|
|||||
|
2020
Q2 | $5.89M | Buy |
|
|||||
|
2020
Q1 | $177K | Sell |
|
|||||
|
2019
Q4 | $930K | Buy |
|